Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Semin Pediatr Surg ; 31(2): 151162, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35690459

RESUMO

Hirschsprung-associated enterocolitis (HAEC) was described in 1886 by Harald Hirschsprung and is a potentially deadly complication of Hirschsprung Disease. HAEC is classically characterized by abdominal distension, fever, and diarrhea, although there can be a variety of other associated symptoms, including colicky abdominal pain, lethargy, and the passage of blood-stained stools. HAEC occurs both pre-operatively and post-operatively, is the presenting symptom of HSCR in up to 25% of infants and varies in overall incidence from 20 to 60%. This article reviews our current understanding of HAEC pathogenesis, diagnosis, and treatment with discussion of areas of ongoing research, controversy, and future investigation.


Assuntos
Enterocolite , Doença de Hirschsprung , Enterocolite/diagnóstico , Enterocolite/etiologia , Enterocolite/terapia , Doença de Hirschsprung/complicações , Doença de Hirschsprung/diagnóstico , Doença de Hirschsprung/cirurgia , Humanos , Lactente
3.
FASEB J ; 34(8): 10931-10947, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32592286

RESUMO

Enteric nervous system (ENS) development is governed by interactions between neural crest cells (NCC) and the extracellular matrix (ECM). Hirschsprung disease (HSCR) results from incomplete NCC migration and failure to form an appropriate ENS. Prior studies implicate abnormal ECM in NCC migration failure. We performed a comparative microarray of the embryonic distal hindgut of wild-type and EdnrBNCC-/- mice that model HSCR and identified laminin-ß1 as upregulated in EdnrBNCC-/- colon. We identified decreased expression of 37/67 kDa laminin receptor (LAMR), which binds laminin-ß1, in human HSCR myenteric plexus and EdnrBNCC-/- NCC. Using a combination of in vitro gut slice cultures and ex vivo organ cultures, we determined the mechanistic role of LAMR in NCC migration. We found that enteric NCC express LAMR, which is downregulated in human and murine HSCR. Binding of LAMR by the laminin-ß1 analog YIGSR promotes NCC migration. Silencing of LAMR abrogated these effects. Finally, applying YIGSR to E13.5 EdnrBNCC-/- colon explants resulted in 80%-100% colonization of the hindgut. This study adds LAMR to the large list of receptors through which NCC interact with their environment during ENS development. These results should be used to inform ongoing integrative, regenerative medicine approaches to HSCR.


Assuntos
Movimento Celular/fisiologia , Sistema Nervoso Entérico/crescimento & desenvolvimento , Sistema Nervoso Entérico/metabolismo , Crista Neural/metabolismo , Receptores de Laminina/metabolismo , Animais , Colo/metabolismo , Colo/fisiologia , Regulação para Baixo/fisiologia , Sistema Nervoso Entérico/fisiologia , Doença de Hirschsprung/metabolismo , Doença de Hirschsprung/fisiopatologia , Humanos , Laminina/metabolismo , Camundongos , Camundongos Knockout , Crista Neural/fisiologia , Organogênese/fisiologia , Receptor de Endotelina B/metabolismo , Regulação para Cima/fisiologia
4.
Elife ; 72018 12 04.
Artigo em Inglês | MEDLINE | ID: mdl-30511640

RESUMO

Systemic blood pressure is determined, in part, by arterial smooth muscle cells (myocytes). Several Transient Receptor Potential (TRP) channels are proposed to be expressed in arterial myocytes, but it is unclear if these proteins control physiological blood pressure and contribute to hypertension in vivo. We generated the first inducible, smooth muscle-specific knockout mice for a TRP channel, namely for PKD2 (TRPP1), to investigate arterial myocyte and blood pressure regulation by this protein. Using this model, we show that intravascular pressure and α1-adrenoceptors activate PKD2 channels in arterial myocytes of different systemic organs. PKD2 channel activation in arterial myocytes leads to an inward Na+ current, membrane depolarization and vasoconstriction. Inducible, smooth muscle cell-specific PKD2 knockout lowers both physiological blood pressure and hypertension and prevents pathological arterial remodeling during hypertension. Thus, arterial myocyte PKD2 controls systemic blood pressure and targeting this TRP channel reduces high blood pressure.


Assuntos
Artérias/metabolismo , Hipertensão/genética , Miócitos de Músculo Liso/metabolismo , Receptores Adrenérgicos alfa 1/genética , Sódio/metabolismo , Canais de Cátion TRPP/genética , Animais , Artérias/fisiopatologia , Pressão Sanguínea/fisiologia , Cátions Monovalentes , Regulação da Expressão Gênica , Membro Posterior/irrigação sanguínea , Membro Posterior/citologia , Hipertensão/metabolismo , Hipertensão/fisiopatologia , Transporte de Íons , Potenciais da Membrana/fisiologia , Camundongos , Camundongos Knockout , Miócitos de Músculo Liso/patologia , Receptores Adrenérgicos alfa 1/metabolismo , Transdução de Sinais , Canais de Cátion TRPP/deficiência , Vasoconstrição/fisiologia
5.
Sci Signal ; 10(478)2017 May 09.
Artigo em Inglês | MEDLINE | ID: mdl-28487419

RESUMO

Membrane depolarization of smooth muscle cells (myocytes) in the small arteries that regulate regional organ blood flow leads to vasoconstriction. Membrane depolarization also activates large-conductance calcium (Ca2+)-activated potassium (BK) channels, which limits Ca2+ channel activity that promotes vasoconstriction, thus leading to vasodilation. We showed that in human and rat arterial myocytes, membrane depolarization rapidly increased the cell surface abundance of auxiliary BK ß1 subunits but not that of the pore-forming BKα channels. Membrane depolarization stimulated voltage-dependent Ca2+ channels, leading to Ca2+ influx and the activation of Rho kinase (ROCK) 1 and 2. ROCK1/2-mediated activation of Rab11A promoted the delivery of ß1 subunits to the plasma membrane by Rab11A-positive recycling endosomes. These additional ß1 subunits associated with BKα channels already at the plasma membrane, leading to an increase in apparent Ca2+ sensitivity and activation of the channels in pressurized arterial myocytes and vasodilation. Thus, membrane depolarization activates BK channels through stimulation of ROCK- and Rab11A-dependent trafficking of ß1 subunits to the surface of arterial myocytes.


Assuntos
Membrana Celular/metabolismo , Subunidades beta do Canal de Potássio Ativado por Cálcio de Condutância Alta/metabolismo , Músculo Liso Vascular/fisiologia , Vasoconstrição , Proteínas rab de Ligação ao GTP/metabolismo , Quinases Associadas a rho/metabolismo , Animais , Cálcio/metabolismo , Movimento Celular , Subunidades beta do Canal de Potássio Ativado por Cálcio de Condutância Alta/genética , Masculino , Potenciais da Membrana , Músculo Liso Vascular/citologia , Subunidades Proteicas , Transporte Proteico , Ratos , Ratos Sprague-Dawley , Transdução de Sinais , Vasodilatação
6.
Am J Physiol Cell Physiol ; 310(11): C1001-9, 2016 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-27147559

RESUMO

Anoctamin-1 [ANO1, also known as transmembrane protein 16A (TMEM16A)] is a Ca(2+)-activated Cl(-) channel expressed in arterial myocytes that regulates membrane potential and contractility. Signaling mechanisms that control ANO1 activity in arterial myocytes are poorly understood. In cerebral artery myocytes, ANO1 channels are activated by local Ca(2+) signals generated by plasma membrane nonselective cation channels, but the molecular identity of these proteins is unclear. Arterial myocytes express several different nonselective cation channels, including multiple members of the transient receptor potential receptor (TRP) family. The goal of this study was to identify localized ion channels that control ANO1 currents in cerebral artery myocytes. Coimmunoprecipitation and immunofluorescence resonance energy transfer microscopy experiments indicate that ANO1 and canonical TRP 6 (TRPC6) channels are present in the same macromolecular complex and localize in close spatial proximity in the myocyte plasma membrane. In contrast, ANO1 is not near TRPC3, TRP melastatin 4, or inositol trisphosphate receptor 1 channels. Hyp9, a selective TRPC6 channel activator, stimulated Cl(-) currents in myocytes that were blocked by T16Ainh-A01, an ANO1 inhibitor, ANO1 knockdown using siRNA, and equimolar replacement of intracellular EGTA with BAPTA, a fast Ca(2+) chelator that abolishes local Ca(2+) signaling. Hyp9 constricted pressurized cerebral arteries, and this response was attenuated by T16Ainh-A01. In contrast, T16Ainh-A01 did not alter depolarization-induced (60 mM K(+)) vasoconstriction. These data indicate that TRPC6 channels generate a local intracellular Ca(2+) signal that activates nearby ANO1 channels in myocytes to stimulate vasoconstriction.


Assuntos
Canais de Cloreto/metabolismo , Músculo Liso Vascular/metabolismo , Miócitos de Músculo Liso/metabolismo , Canais de Cátion TRPC/metabolismo , Vasoconstrição , Animais , Anoctamina-1 , Quelantes de Cálcio/farmacologia , Sinalização do Cálcio , Artérias Cerebrais/metabolismo , Canais de Cloreto/antagonistas & inibidores , Canais de Cloreto/genética , Masculino , Potenciais da Membrana , Músculo Liso Vascular/efeitos dos fármacos , Miócitos de Músculo Liso/efeitos dos fármacos , Interferência de RNA , Ratos Sprague-Dawley , Canais de Cátion TRPC/agonistas , Técnicas de Cultura de Tecidos , Transfecção , Vasoconstrição/efeitos dos fármacos , Vasoconstritores/farmacologia
7.
Exp Neurol ; 283(Pt A): 110-20, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27163549

RESUMO

A missense mutation in CIZ1 (c.790A>G, p.S264G) was linked to autosomal dominant cervical dystonia in a large multiplex Caucasian pedigree (OMIM614860, DYT23). CIZ1 is a p21((Cip1/Waf1)) -interacting zinc finger protein, widely expressed in neural and extra-neural tissues, and plays a role in DNA synthesis at the G1/S cell-cycle checkpoint. The role of CIZ1 in the nervous system and relative contributions of gain- or loss- of function to the pathogenesis of CIZ1-associated dystonia remain indefinite. Using relative quantitative reverse transcriptase-PCR, cerebellum showed the highest expression levels of Ciz1 in adult mouse brain, over two fold higher than liver, and higher than striatum, midbrain and cerebral cortex. Overall, neural expression of Ciz1 increased with postnatal age. A Ciz1 gene-trap knock-out (KO) mouse model (Ciz1(-/-)) was generated to examine the functional role(s) of CIZ1 in the sensorimotor nervous system and contributions of CIZ1 to cell-cycle control in the mammalian brain. Ciz1 transcripts were absent in Ciz1(-/-) mice and reduced by approximately 50% in Ciz1(+/-) mice. Ciz1(-/-) mice were fertile but smaller than wild-type (WT) littermates. Ciz1(-/-) mice did not manifest dystonia, but exhibited mild motoric abnormalities on balance, open-field activity, and gait. To determine the effects of germline KO of Ciz1 on whole-genome gene expression in adult brain, total RNA from mouse cerebellum was harvested from 6 10-month old Ciz1(-/-) mice and 6 age- and gender- matched WT littermates for whole-genome gene expression analysis. Based on whole-genome gene-expression analyses, genes involved in cellular movement, cell development, cellular growth, cellular morphology and cell-to-cell signaling and interaction were up-regulated in Ciz1(-/-) mice. The top up-regulated pathways were metabolic and cytokine-cytokine receptor interactions. Down-regulated genes were involved in cell cycle, cellular development, cell death and survival, gene expression and cell morphology. Down-regulated networks included those related to metabolism, focal adhesion, neuroactive ligand-receptor interaction, and MAPK signaling. Based on pathway analyses, transcription factor 7-like 2 (TCF7L2), a member of the Wnt/ß-catenin signaling pathway, was a major hub for down-regulated genes, whereas NF-κB was a major hub for up-regulated genes. In aggregate, these data suggest that CIZ1 may be involved in the post-mitotic differentiation of neurons in response to external signals and changes in gene expression may compensate, in part, for CIZ1 deficiency in our Ciz1(-/-) mouse model. Although CIZ1 deficiency was associated with mild motor abnormalities, germline loss of Ciz1 was not associated with dystonia on the C57BL/6J background.


Assuntos
Encéfalo/metabolismo , Redes Reguladoras de Genes/genética , Transtornos dos Movimentos , Proteínas Nucleares/deficiência , Proteínas Nucleares/genética , Transdução de Sinais/genética , Fatores Etários , Animais , Animais Recém-Nascidos , Encéfalo/crescimento & desenvolvimento , Modelos Animais de Doenças , Comportamento Exploratório/fisiologia , Feminino , Marcha/genética , Marcha/fisiologia , Genoma/genética , Masculino , Camundongos , Camundongos Transgênicos , Transtornos dos Movimentos/genética , Transtornos dos Movimentos/patologia , Transtornos dos Movimentos/fisiopatologia , Força Muscular/genética , Equilíbrio Postural/genética , Desempenho Psicomotor/fisiologia , Reflexo/genética , Fatores Sexuais
8.
Am J Physiol Cell Physiol ; 309(6): C392-402, 2015 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-26179602

RESUMO

Arterial smooth muscle cells (myocytes) express large-conductance Ca(2+)-activated K(+) (BK) channel α and auxiliary ß1 subunits that modulate arterial contractility. In arterial myocytes, ß1 subunits are stored within highly mobile rab11A-positive recycling endosomes. In contrast, BKα subunits are primarily plasma membrane-localized. Trafficking pathways for BKα and whether physiological stimuli that regulate arterial contractility alter BKα localization in arterial myocytes are unclear. Here, using biotinylation, immunofluorescence resonance energy transfer (immunoFRET) microscopy, and RNAi-mediated knockdown, we demonstrate that rab4A-positive early endosomes traffic BKα to the plasma membrane in myocytes of resistance-size cerebral arteries. Angiotensin II (ANG II), a vasoconstrictor, reduced both surface and total BKα, an effect blocked by bisindolylmaleimide-II, concanavalin A, and dynasore, protein kinase C (PKC), internalization, and endocytosis inhibitors, respectively. In contrast, ANG II did not reduce BKα mRNA, and sodium nitroprusside, a nitric oxide donor, did not alter surface BKα protein over the same time course. MG132 and bafilomycin A, proteasomal and lysosomal inhibitors, respectively, also inhibited the ANG II-induced reduction in surface and total BKα, resulting in intracellular BKα accumulation. ANG II-mediated BK channel degradation reduced BK currents in isolated myocytes and functional responses to iberiotoxin, a BK channel blocker, and NS1619, a BK activator, in pressurized (60 mmHg) cerebral arteries. These data indicate that rab4A-positive early endosomes traffic BKα to the plasma membrane in arterial myocytes. We also show that ANG II stimulates PKC-dependent BKα internalization and degradation. These data describe a unique mechanism by which ANG II inhibits arterial myocyte BK currents, by reducing surface channel number, to induce vasoconstriction.


Assuntos
Angiotensina II/farmacologia , Membrana Celular/metabolismo , Artérias Cerebrais/metabolismo , Canais de Potássio Ativados por Cálcio de Condutância Alta/metabolismo , Células Musculares/metabolismo , Proteólise/efeitos dos fármacos , Vasoconstrição/efeitos dos fármacos , Animais , Artérias Cerebrais/efeitos dos fármacos , Endossomos/efeitos dos fármacos , Endossomos/metabolismo , Masculino , Potenciais da Membrana/efeitos dos fármacos , Células Musculares/efeitos dos fármacos , Músculo Liso Vascular/efeitos dos fármacos , Músculo Liso Vascular/metabolismo , Miócitos de Músculo Liso/efeitos dos fármacos , Miócitos de Músculo Liso/metabolismo , Ratos , Ratos Sprague-Dawley , Vasoconstritores/farmacologia
9.
J Neurol Sci ; 331(1-2): 31-7, 2013 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-23726276

RESUMO

Oxidative stress-induced neuronal cell death has been implicated in Parkinson's disease (PD). Oxidative stress initiated by 6-hydroxydopamine (6-OHDA) causes mitochondrial dysfunction leading to apoptosis and Parkinsonian neurodegeneration. We investigated the neuroprotective potential of serotonin (5-HT), gamma amino butyric acid (GABA) and autologous bone marrow cells (BMC) in combination against oxidative stress-induced cell death. PD was induced in adult male Wistar rats by intranigral infusion of 6-OHDA (8 µg/µl). The activities of antioxidant enzymes--superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were analysed. The extent of lipid peroxidation was quantified by measuring the formation of thiobarbituric acid reactive substances (TBARs). Real Time PCR gene expression of SOD, CAT and GPx were performed using specific Taqman probes. 6-OHDA induced decreased activity of SOD, CAT and GPx in corpus striatum was significantly reversed to near control (p<0.001) by treatment with 5-HT, GABA and bone marrow cells. Gene expression studies of SOD, CAT and GPx using Real Time PCR confirmed the above observation. TBAR levels were elevated (p<0.001) in 6-OHDA treated rats indicating lipid peroxidation. 5-HT and GABA along with autologous bone marrow cell supplementation significantly ameliorated 6-OHDA-induced lipid peroxidation (p<0.001). Our results suggest a new therapeutic strategy of neuroprotection against damage by oxidative stress in Parkinson's disease.


Assuntos
Adrenérgicos/toxicidade , Transplante de Medula Óssea/métodos , Corpo Estriado , Oxidopamina/toxicidade , Doença de Parkinson , Serotonina/uso terapêutico , Ácido gama-Aminobutírico/uso terapêutico , Análise de Variância , Animais , Catalase/genética , Catalase/metabolismo , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/metabolismo , Corpo Estriado/patologia , Modelos Animais de Doenças , Glutationa Peroxidase/genética , Glutationa Peroxidase/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/fisiologia , Doença de Parkinson/etiologia , Doença de Parkinson/patologia , Doença de Parkinson/terapia , Ratos , Ratos Wistar , Superóxido Dismutase/genética , Superóxido Dismutase/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
10.
Parkinsonism Relat Disord ; 17(4): 255-9, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21306935

RESUMO

Parkinson's disease is a progressive neurodegenerative disorder characterized by selective degeneration of dopaminergic neurons in substantia nigra pars compacta leading to marked reduction of dopamine levels in the cerebral cortex. The present study analysed the effect of serotonin, dopamine and norepinephrine as treatment on rotenone induced Hemi-Parkinson's disease in rats and its role in the regulation of dopamine receptor subtypes in the cerebral cortex of the experimental rats. Unilateral stereotaxic single dose infusions of rotenone were administered to the substantia nigra of adult male Wistar rats. Neurotransmitters--serotonin, dopamine and norepinephrine treatments--were given to rotenone induced Hemi-Parkinson's rats. Scatchard analysis of Dopamine D1 and D2 receptor showed a significant increase (p < 0.001) in the cerebral cortex of the Parkinson's rats compared to control. These altered parameters were reversed to near control in the serotonin and norepinephrine treated Parkinson's disease rats and no change was observed in dopamine treated Parkinson's rats. Real-time PCR results confirmed the receptor data. Our results showed serotonin and norepinephrine functionally reversed the dopamine receptors significantly in rotenone induced Hemi-Parkinson's rat. This has clinical significance in the therapeutic management of Parkinson's disease.


Assuntos
Córtex Cerebral/efeitos dos fármacos , Neurotransmissores/farmacologia , Transtornos Parkinsonianos/tratamento farmacológico , Receptores de Dopamina D1/metabolismo , Receptores de Dopamina D2/metabolismo , Animais , Dopamina/metabolismo , Dopamina/farmacologia , Lateralidade Funcional , Masculino , Norepinefrina/metabolismo , Norepinefrina/farmacologia , Transtornos Parkinsonianos/metabolismo , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Rotenona/toxicidade , Serotonina/metabolismo , Serotonina/farmacologia , Desacopladores/toxicidade
11.
J Biomed Sci ; 18: 5, 2011 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-21235809

RESUMO

Parkinson's disease is characterized by progressive cell death in the substantia nigra pars compacta, which leads to dopamine depletion in the striatum and indirectly to cortical dysfunction. Increased glutamatergic transmission in the basal ganglia is implicated in the pathophysiology of Parkinson's disease and glutamate receptor mediated excitotoxicity has been suggested to be one of the possible causes of the neuronal degeneration. In the present study, the effects of serotonin, gamma-aminobutyric acid and bone marrow cells infused intranigrally to substantia nigra individually and in combination on unilateral 6-hydroxydopamine induced Parkinson's rat model was analyzed. Scatchard analysis of total glutamate and NMDA receptor binding parameters showed a significant increase in Bmax (P < 0.001) in the cerebral cortex of 6-hydroxydopamine infused rat compared to control. Real Time PCR amplification of NMDA2B, mGluR5, bax, and ubiquitin carboxy-terminal hydrolase were up regulated in cerebral cortex of 6-hydroxydopamine infused rats compared to control. Gene expression studies of GLAST, ά-Synuclien and Cyclic AMP response element-binding protein showed a significant (P < 0.001) down regulation in 6-OHDA infused rats compared to control. Behavioural studies were carried out to confirm the biochemical and molecular studies. Serotonin and GABA along with bone marrow cells in combination showed reversal of glutamate receptors and behaviour abnormality shown in the Parkinson's rat model. The therapeutic significance in Parkinson's disease is of prominence.


Assuntos
Transplante de Medula Óssea , Córtex Cerebral/metabolismo , AMP Cíclico/metabolismo , Ácido Glutâmico/metabolismo , Fosfatos de Inositol/metabolismo , Oxidopamina/efeitos adversos , Doença de Parkinson Secundária/metabolismo , Serotonina/metabolismo , Ácido gama-Aminobutírico/metabolismo , Animais , Comportamento Animal/efeitos dos fármacos , Células da Medula Óssea/metabolismo , Córtex Cerebral/patologia , Modelos Animais de Doenças , Masculino , Oxidopamina/farmacologia , Doença de Parkinson Secundária/induzido quimicamente , Doença de Parkinson Secundária/patologia , Doença de Parkinson Secundária/terapia , Ratos , Ratos Wistar , Substância Negra/metabolismo , Substância Negra/patologia , Transplante Homólogo
12.
Neurochem Res ; 36(1): 7-16, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20821261

RESUMO

In the present study, alterations of the General GABA and GABA(A) receptors in the hippocampus of pilocarpine-induced temporal lobe epileptic rats and the therapeutic application of Bacopa monnieri and its active component Bacoside-A were investigated. Bacopa monnieri (Linn.) is a herbaceous plant belonging to the family Scrophulariaceae. Hippocampus is the major region of the brain belonging to the limbic system and plays an important role in epileptogenesis, memory and learning. Scatchard analysis of [³H]GABA and [³H]bicuculline in the hippocampus of the epileptic rat showed significant decrease in B(max) (P < 0.001) compared to control. Real Time PCR amplification of GABA(A) receptor sub-units such as GABA(Aά1), GABA(Aά5) GABA(Aδ), and GAD were down regulated (P < 0.001) in the hippocampus of the epileptic rats compared to control. GABA(Aγ) subunit was up regulated. Epileptic rats have deficit in the radial arm and Y maze performance. Bacopa monnieri and Bacoside-A treatment reverses all these changes near to control. Our results suggest that decreased GABA receptors in the hippocampus have an important role in epilepsy associated behavioral deficit, Bacopa monnieri and Bacoside-A have clinical significance in the management of epilepsy.


Assuntos
Bacopa/química , Comportamento Animal/fisiologia , Epilepsia/tratamento farmacológico , Hipocampo/metabolismo , Extratos Vegetais/uso terapêutico , Receptores de GABA/metabolismo , Animais , Anticonvulsivantes/farmacologia , Bacopa/metabolismo , Comportamento Animal/efeitos dos fármacos , Carbamazepina/farmacologia , Epilepsia/fisiopatologia , Hipocampo/efeitos dos fármacos , Masculino , Testes Neuropsicológicos , Extratos Vegetais/farmacologia , Ratos , Ratos Wistar , Saponinas/metabolismo , Saponinas/farmacologia , Saponinas/uso terapêutico , Triterpenos/metabolismo , Triterpenos/farmacologia , Triterpenos/uso terapêutico
13.
Mol Cell Endocrinol ; 331(1): 1-10, 2011 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-20637830

RESUMO

Diabetes exacerbates neuronal injury mediated through neurotransmitters deregulation in cerebral cortex. Our study analyzed the neuroprotective effect of curcumin to prevent cortical dysfunction associated with diabetes. Our study revealed decreased gene expression of muscarinic M1, insulin receptor, SOD, choline acetyl transferase and increased gene expression of muscarinic M3, α7-nicotinic acetylcholine receptor, acetylcholine esterase and GLUT3 in cerebral cortex of diabetic rats. Curcumin and insulin treatment reversed this altered parameters to near control. Immunohistochemistry studies of muscarinic M1 and M3 confirmed the gene expression at protein level. Decreased novel arm entry of diabetic rats in Y-maze test, improved in treatment group. These results suggest that cholinergic dysfunction, impaired glucose transport and oxidative stress contributes to learning and memory deficits in diabetes and further suggest that antioxidant curcumin has potential therapeutic role in preventing and/or delaying the diabetic complications associated with brain.


Assuntos
Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/fisiopatologia , Curcumina/farmacologia , Diabetes Mellitus Experimental/prevenção & controle , Diabetes Mellitus Experimental/fisiopatologia , Receptores Colinérgicos/metabolismo , Acetilcolinesterase/genética , Acetilcolinesterase/metabolismo , Animais , Anticorpos/metabolismo , Atropina/metabolismo , Córtex Cerebral/citologia , Colina O-Acetiltransferase/genética , Colina O-Acetiltransferase/metabolismo , Ácidos Difenilacéticos/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Transportador de Glucose Tipo 3/genética , Transportador de Glucose Tipo 3/metabolismo , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Piperidinas/metabolismo , Pirenzepina/metabolismo , Ratos , Ratos Wistar , Receptor de Insulina/genética , Receptor de Insulina/metabolismo , Receptor Muscarínico M1/genética , Receptor Muscarínico M1/metabolismo , Receptor Muscarínico M3/genética , Receptor Muscarínico M3/metabolismo , Receptores Nicotínicos/genética , Receptores Nicotínicos/metabolismo , Superóxido Dismutase/genética , Superóxido Dismutase/metabolismo , Receptor Nicotínico de Acetilcolina alfa7
14.
Neurol Res ; 32(9): 918-24, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20887679

RESUMO

UNLABELLED: Parkinson's disease (PD) is due to widespread degeneration in the central and peripheral nervous systems. The hallmark pathology remains in the dopaminergic striatal insufficiency and degeneration of dopaminergic neurons in the substantia nigra. OBJECTIVES: The present study analysed the effect of serotonin (5-HT), dopamine, and norepinephrine as treatment on rotenone induced hemi-Parkinson's disease in rats and its role in the regulation of dopamine receptor subtypes in the corpus striatum of the experimental rats. METHODS: Unilateral stereotaxic single-dose infusions of rotenone were administered to the substantia nigra of adult male Wistar rats. Neurotransmitters serotonin (5-HT), dopamine, and norepinephrine treatments were given to rotenone induced hemi-Parkinson's rats. Dopamine receptor and its subtypes (D1 and D2) binding assay were carried out. Gene expression studies of dopamine D1 and D2 were carried out using real-time PCR. RESULTS: Scatchard analysis of dopamine and dopamine D2 receptor showed a significant increase (P<0.001) and dopamine D1 receptor showed a significant decrease (P<0.001) in the B(max) in corpus striatum of the PD rats compared to control. These altered parameters were reversed to near control in the serotonin- and norepinephrine-treated PD rats and no change was observed in dopamine-treated PD rats. Real-time PCR results confirmed the receptor data. CONCLUSION: Our results showed that serotonin and norepinephrine functionally reversed in dopamine receptors in rotenone-induced hemi-Parkinson's rat. This has clinical significance in the therapeutic management of PD.


Assuntos
Catecolaminas/farmacologia , Corpo Estriado/efeitos dos fármacos , Transtornos Parkinsonianos/patologia , Receptores de Dopamina D1/metabolismo , Receptores de Dopamina D2/metabolismo , Animais , Benzamidas/farmacocinética , Benzazepinas/farmacocinética , Corpo Estriado/diagnóstico por imagem , Corpo Estriado/metabolismo , Modelos Animais de Doenças , Dopamina/farmacologia , Antagonistas de Dopamina/farmacocinética , Antagonistas dos Receptores de Dopamina D2 , Interações Medicamentosas , Lateralidade Funcional , Masculino , Norepinefrina/farmacologia , Transtornos Parkinsonianos/induzido quimicamente , Ligação Proteica/efeitos dos fármacos , Cintilografia , Ratos , Ratos Wistar , Teste de Desempenho do Rota-Rod , Rotenona/análogos & derivados , Serotonina/farmacologia , Trítio/farmacocinética
15.
J Biomed Sci ; 17: 78, 2010 Sep 25.
Artigo em Inglês | MEDLINE | ID: mdl-20868513

RESUMO

Diabetes and stress stimulate hippocampal 5-HT synthesis, metabolism and release. The present study was carried out to find the effects of insulin, Aegle marmelose alone and in combination with pyridoxine on the hippocampal 5-HT, 5-HT(2A) receptor subtype, gene expression studies on 5-HT(2A), 5-HTT, INSR, immunohistochemical studies and elevated plus maze in streptozotocin induced diabetic rats. 5-HT content showed a significant decrease (p < 0.001) and a significant increase (p < 0.001) in 5-HIAA in hippocampus of diabetic rats compared to control. 5-HT receptor binding parameters B(max) and Kd showed a significant decrease (p < 0.001) whereas 5-HT(2A) receptor binding parameters Bmax showed a significant decrease (p < 0.001) with a significant increase (p < 0.05) in Kd in hippocampus of diabetic rats compared to control. Gene expression studies of 5-HT(2A), 5-HTT and INSR in hippocampus showed a significant down regulation (p < 0.001) in diabetic rats compared to control. Pyridoxine treated in combination with insulin and A. marmelose to diabetic rats reversed the 5-HT content, B(max), Kd of 5-HT, 5-HT(2A) and gene expression of 5-HT(2A), 5-HTT and INSR in hippocampus to near control. The gene expression of 5-HT(2A) and 5-HTT were confirmed by immunohistochemical studies. Behavioural studies using elevated plus maze showed that serotonin through its transporter significantly increased (p < 0.001) anxiety-related traits in diabetic rats which were corrected by combination therapy. Our results suggest that pyridoxine treated in combination with insulin and A. marmelose has a role in the regulation of insulin synthesis and release, normalising diabetic related stress and anxiety through hippocampal serotonergic function. This has clinical significance in the management of diabetes.


Assuntos
Aegle/química , Diabetes Mellitus Experimental/metabolismo , Hipocampo , Extratos Vegetais/farmacologia , Piridoxina/farmacologia , Receptor de Insulina/metabolismo , Serotonina/metabolismo , Estresse Fisiológico , Animais , Comportamento Animal/efeitos dos fármacos , Glicemia/metabolismo , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Masculino , Fármacos Neuroprotetores/metabolismo , Fármacos Neuroprotetores/farmacologia , Testes Neuropsicológicos , Extratos Vegetais/metabolismo , Piridoxina/metabolismo , Distribuição Aleatória , Ratos , Ratos Wistar , Receptor 5-HT2A de Serotonina/genética , Receptor 5-HT2A de Serotonina/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Estreptozocina , Complexo Vitamínico B/metabolismo , Complexo Vitamínico B/farmacologia
16.
Neurochem Res ; 35(10): 1516-21, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20532620

RESUMO

Hypoglycemia is the major problem to blood glucose homeostasis in treatment of diabetes and is associated with severe irreversible consequences including seizures, coma and death. GABAergic inhibitory function in the cerebral cortex plays an important role in controlling the excitability and responsiveness of cortical neurons. Present study analysed effects of insulin induced hypoglycemia and streptozotocin induced diabetes on the cortical GABA receptor binding, GABA(Aά1), GABA(B) receptor subtype expression, GAD and GLUT3 expression. Diabetic rats showed decreased [(3)H] GABA binding in the cerebral cortex compared to control while hypoglycemia exacerbated the decrease. GABA receptor subunits; GABA(Aά1), GABA(B) and GAD expression significantly decreased in diabetic rats whereas hypoglycemia significanly decreased the expression compared to diabetic. GLUT3 expression significantly up regulated during both hypo and hyperglycemia. Our results showed that hypoglycemia and hyperglycemia decreased GABAergic neuroprotective function in the cerebral cortex, which account for the increased vulnerability of cerebral cortex to subsequent neuronal damage during hypo/hyperglycemia.


Assuntos
Córtex Cerebral/metabolismo , Diabetes Mellitus Experimental/metabolismo , Hipoglicemia/metabolismo , Insulina , Receptores de GABA/biossíntese , Estreptozocina , Animais , Glicemia/metabolismo , Diabetes Mellitus Experimental/induzido quimicamente , Regulação da Expressão Gênica , Glutamato Descarboxilase/biossíntese , Glutamato Descarboxilase/genética , Hipoglicemia/induzido quimicamente , Masculino , Ligação Proteica , Subunidades Proteicas/biossíntese , Subunidades Proteicas/genética , Ratos , Ratos Wistar , Receptores de GABA/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...